|
Jul 29
|
Vor Biopharma (VOR) Jumps 10% on Addition of 2 CEOs to Board
|
|
Jul 23
|
Solid Biosciences Receives FDA Fast Track Designation for SGT-501 First-in-Class Gene Therapy for Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)
|
|
Jul 21
|
Vor Bio Appoints Biotech Industry Leaders Alexander (Bo) Cumbo and Michel Detheux, Ph.D. to Board of Directors
|
|
Jul 9
|
Citi Initiates Coverage on Solid Biosciences Inc. (SLDB) with ‘Buy’ Rating and $14 PT
|
|
Jul 8
|
Solid Biosciences Announces FDA IND and Health Canada CTA Approval for First-in-Class Cardiac Gene Therapy to Treat Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)
|
|
Jun 26
|
General Mills upgraded, Trade Desk downgraded: Wall Street's top analyst calls
|
|
Mar 15
|
Solid Biosciences Inc. (SLDB): Among Top Insider Purchases Last Month
|
|
Mar 12
|
Solid Biosciences to Present at the 2025 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference
|
|
Feb 19
|
Biotech Stock Roundup: MRNA's Q4 Results, GILD's Update & Other News
|
|
Feb 19
|
Solid Biosciences’ stock soars on early success in DMD gene therapy trial
|
|
Feb 18
|
Solid Biosciences Shares Up After Positive Results From Duchenne Drug Study, Prices $200 Million Offering
|
|
Feb 18
|
Solid Biosciences Announces Pricing of Underwritten Offering
|
|
Feb 18
|
Solid Biosciences Reports Positive Initial Clinical Data from Next-Generation Duchenne Gene Therapy Candidate SGT-003
|
|
Feb 18
|
Solid says early data suggest ‘differentiated’ Duchenne gene therapy
|
|
Sep 23
|
Solid Biosciences to Participate at Chardan’s 8th Annual Genetic Medicines Conference
|
|
Aug 13
|
Solid Biosciences Reports Second Quarter 2024 Financial Results and Provides Business Updates
|
|
Jul 1
|
Solid Biosciences Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
|
|
Jul 1
|
Solid Biosciences Joins the Russell 3000® Index
|
|
Jun 2
|
We Think Solid Biosciences (NASDAQ:SLDB) Can Afford To Drive Business Growth
|
|
May 15
|
Solid Biosciences Provides First Quarter 2024 Business Update and Financial Results
|